The apheresis of low-density lipoproteins in homozygous familial hypercholesterolemia
Ros Rahola, E.
Medicina Clinica 100(3): 117-118
1993
ISSN/ISBN: 0025-7753 PMID: 8426494 Document Number: 420332
Document emailed within 1 workday
Related Documents
Iarovaia, E.B.; Rostapshova, T.V.; Susekov, A.V.; Kukharchuk, V.V. 1993: The choice of the optimal regimen for apheresis of the low-density lipoproteins in patients with familial hypercholesterolemia by using mathematical modelling Kardiologiia 33(10): 50Napoli, C.; Postiglione, A.; Scarpato, N.; Corso, G.; Ambrosio, G.; Condorelli, M.; Mancini, M.; Chiariello, M. 1996: LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment Cardiologia 41(5): 435-439
Saku, K.; Takeda, Y.; Jimi, S.; Okabe, M.; Shirai, K.; Nii, T.; Naito, S.; Arakawa, K. 1998: Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography Journal of Cardiology 31(4): 239-245
Semenkovich, C.F.; Ostlund, R.E.; Yang, J.; Reaban, M.E. 1985: Demonstration of functional low-density lipoprotein receptors by protein blotting in fibroblasts from a subject with homozygous receptor-negative familial hypercholesterolemia Journal of Laboratory and Clinical Medicine 106(1): 47-52
Dairou, F.; Rottembourg, J.; de Gennes, J.L.; Assogba, U.; Bruckert, E.; Jacobs, C.; Truffert, J. 1988: Comparison between treatments of severe forms of familial hypercholesterolemia by total plasma exchange and selective removal of low density lipoproteins (LDLapheresis) Presse Medicale 17(33): 1679-1682
Bláha, V.ír.; Bláha, M.; Lánská, M.; Havel, E.; Vyroubal, P.; Zadák, Z.ěk.; Žák, P.; Sobotka, L.š 2014: LDL-apheresis in the treatment familial hypercholesterolemia Vnitrni Lekarstvi 60(11): 970-976
Marson, P.; Boschetto, R.; De Silvestro, G.; Martini, S.; Gabelli, C.; Buoro, S.; Giordano, R.; Palù, G. 1999: Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia International Journal of Artificial Organs 22(9): 640-644
Gilsanz Peral, A.; Dalmau Serra, J.; Bretó Gilabert, M. 1992: Treatment difficulty in familial homozygous hypercholesterolemia Medicina Clinica 99(2): 78
Bokchubaev, E.T.; Kukharchuk, V.V.; Nasonov, E.L.; Konovalov, G.A.; Masenko, V.P. 1992: Effect of low-density lipoprotein apheresis on the complement system in patients with hereditary hypercholesterolemia Klinicheskaia Meditsina 70(9-10): 45-48
Turk, Z.; Mrzljak, V.; Turk, N.; Metelko, Z. 1999: Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis Diabetes Nutrition and Metabolism 12(6): 413-417
Castilla Cabezas, J.A.; López-Cillero, P.; Jiménez, J.; Fraga, E.; Arizón, J.M.; Briceño, J.; Solórzano, G.; De la Mata, M.; Pera, C. 2000: Role of orthotopic liver transplant in the treatment of homozygous familial hypercholesterolemia Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 92(9): 601-608
Konovalov, G.A. 1991: Extracorporeal methods for low-density lipoprotein apheresis in treating patients with severe forms of hereditary hypercholesterolemia. a review Terapevticheskii Arkhiv 63(10): 111-119
Bokchubaev, E.T.; Konovalov, G.A.; Nasonov, E.L.; Kukharchuk, V.V. 1991: The dynamics of the concentrations of immunoglobulins and circulating immune complexes during low-density lipoprotein apheresis in patients with hereditary hypercholesterolemia Terapevticheskii Arkhiv 63(9): 62-64
Tilly-Kiesi, M.; Tikkanen, M.J. 1992: Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia Journal of Laboratory and Clinical Medicine 120(1): 103-110
Konovalov, G.A.; Pokrovskiĭ, S.N.; Trakht, I.N.; Bokchubaev, E.; Volkova, E.I.; Kukharchuk, V.V. 1991: The plasmoimmunosorption of low-density lipoproteins in the treatment of patients with hereditary hypercholesterolemia Terapevticheskii Arkhiv 63(7): 65-70
Nofer, J.R.; Tepel, M.; Kehrel, B.; Wierwille, S.; Walter, M.; Seedorf, U.; Zidek, W.; Assmann, G. 1997: Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia Circulation 95(6): 1370-1377
Riesen, W.F.; Descoeudres, C.; Mordasini, R.; Girod, M.A. 1989: Selective elimination of atherogenic lipoproteins using dextran-sulfate cellulose. Experiences in 2 patients with heterozygote familial hypercholesterolemia Schweizerische Medizinische Wochenschrift 119(2): 55-58
Meshkov, A.N.; Stambol'skiĭ, D.V.; Krapivner, S.R.; Bochkov, V.N.; Kukharchuk, V.V.; Malyshev, P.P. 2004: Low density lipoprotein receptor gene mutations in patients with clinical diagnosis of familial hypercholesterolemia Kardiologiia 44(9): 58-61
Mandel'shtam, M.I.; Lipovetskiĭ, B.M.; Shvartsman, A.L.; Gaĭtskhoki, V.S. 1995: A multiexon deletion in the human low density lipoprotein receptor gene as a reason for familial hypercholesterolemia Genetika 31(2): 259-263
Hailer, S.; Pogarell, O.; Keller, C.; Wolfram, G. 1996: Effect of fluvastatin or bezafibrate on the distribution of high density lipoprotein subpopulations in patients with familial hypercholesterolemia Arzneimittel-Forschung 46(9): 879-883